Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) was reiterated as Outperform and the price target was raised to $90 from $50 (versus a $66.00 close) at Credit Suisse. The firm said that it has more confidence in FAP success and opportunity and platform de-risking.
Builders FirstSource Inc. (NASDAQ: BLDR) was started with an Outperform rating and assigned a $20 price target at Wedbush, noting that they would focus on positive long-term demand trends rather than the volatile lumber prices.
Church & Dwight Co. Inc. (NYSE: CHD) was downgraded to Underweight from Equal Weight at Morgan Stanley. Shares were indicated down 0.6% at $49.95 on Tuesday, in a 52-week range of $42.56 to $53.68.
Crane Co. (NYSE: CR) was raised to Buy from Hold with a $92 price target (versus a $78.55 close) at Canaccord Genuity.
Delek US Holdings Inc. (NYSE: DK) was raised to Buy from Neutral with a $30 price target (versus a $24.65 close) at Goldman Sachs.
Dr Pepper Snapple Group Inc. (NYSE: DPS) was raised to Overweight from Equal Weight at Morgan Stanley.
Emerson Electric Co. (NYSE: EMR) at Argus, noting that the recent weakness offers a buying opportunity. The firm noted that the company recently reported stronger-than-expected first-quarter results and raised guidance but that it has underperformed the broader market.
FirstCash Inc. (NYSE: FCFS) was maintained as Buy with a $55 fair value estimate, noting that the debt deal is likely accretive to earnings, at Janney.
Forterra Inc. (NASDAQ: FRTA) was down 24% at $14.93 on Monday and hit a new 52-week low of $13.81 after earnings. Forterra was downgraded to Hold at SunTrust Robinson Humphrey and was downgraded to Sector Perform at RBC Capital Markets.
Kroger Co. (NYSE: KR) was started as Hold at Loop Capital.
MDC Holdings Inc. (NYSE: MDC) was downgraded to Underperform from Market Perform at Wells Fargo.
Medtronic PLC (NYSE: MDT) was started as Neutral with an $87 target price (versus an $84.14 close) at Goldman Sachs.
Patheon N.V. (NASDAQ: PTHN) was acquired in a deal by Thermo Fisher. Jefferies downgraded Patheon to Hold based on the high probability of a the deal closing. Jefferies also maintained a Hold rating and $175 target on Thermo Fisher Scientific Inc. (NYSE: TMO) as well.
Sage Therapeutics Inc.(NASDAQ: SAGE) was started as Buy and assigned an $82 price target at Needham.
Select Energy Services Inc. (NYSE: WTTR) was started as Outperform with a $20 target price at Credit Suisse. The report noted that Select Energy Services is a full-service water company and is in one of the most misunderstood sub-segments in OFS, and that it leads the industry with 7% to 10% market share. Merrill Lynch started it as Buy and gave a $20 price objective too. JPMorgan started it as Neutral with a $16 price target. Select Energy closed at $15.29 on Monday and has a post-IPO trading range of $14.00 to $16.55.
Sysco Corp. (NYSE: SYY) was started with a Buy rating and assigned a $61 price target (versus a $54.04 close) at Loop Capital. Sysco has a consensus analyst target price of $55.79.
United Natural Foods Inc. (NASDAQ: UNFI) was started with a Buy rating and assigned a $48 price target at Loop Capital.
US Foods Holding Corp. (NYSE: USFD) was reinstated with an Outperform rating and the new price target is $35 (up from $32 previously) at Credit Suisse, and the firm added it to the Focus List. Credit Suisse sees it as an investment idea in the consumer spending segment with material upside.
Zimmer Biomet Holdings Inc. (NYSE: ZBH) was started with a Sell rating at Goldman Sachs and assigned a $92 price target at Goldman Sachs.
There were two positive views about investor interest in Europe. Merrill Lynch noted that its allocation to European Equities is the highest in two years. Credit Suisse noted that overall client inflows to U.S. equity funds have faded as inflows to Europe have strengthened.
Monday’s top analyst upgrades and downgrades included Applied Materials, Cerner, Cisco, Johnson & Johnson, Level 3 Communications, CenturyLink, Salesforce.com and over a dozen more.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.